Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 53 clinical trials
featured
A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who have Advanced Liver Disease or are Post-Liver Transplant

A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who

  • 444 views
  • 08 Nov, 2020
  • 1 location
Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML

This is a research study of ribavirin which will be given in combination with vismodegib and/or decitabine. The purpose of this study is to see if patients respond to treatment when ribavirin

serum bilirubin level
decitabine
  • 53 views
  • 08 Nov, 2020
  • 1 location
Interferon and Ribavirin Treatment in Patients With Hemoglobinopathies

safety of combination therapy with pegylated interferon and ribavirin in thalassemic patients. This study is carried ahead to assess the impact of combination therapy with pegylated-interferon

thalassemia
hepatitis b
ribavirin
  • 0 views
  • 07 Nov, 2020
  • 1 location
IFN Beta-1b and Ribavirin for Covid-19

ribavirin combination treatment for patients hospitalized for COVID-19 infection.

antiviral drugs
SARS
interferon
critical illness
  • 0 views
  • 06 Aug, 2020
  • 1 location
Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral Activity

not able to clear the virus from their liver. While HBV treatments are typically administered alone (monotherapy), this study will explore the use of Ribavirin in combination with standard therapy to

hepatitis b surface
antiviral therapy
hepatitis b antigen
liver failure
tenofovir
  • 0 views
  • 21 Sep, 2020
  • 2 locations
Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels

Patients with chronic hepatitis C with persistently normal alanine aminotransferase (ALT) levels have been generally excluded from treatment, because the strong conviction that normal ALT would be synonymous of absence of liver damage. However, recent studies have demonstrated marked liver fibrosis, including cirrhosis, in patients with HCV and persistently normal …

blood pregnancy test
interferon
fibrosis
hepatocellular carcinoma
cirrhosis
  • 7 views
  • 07 Nov, 2020
  • 1 location
RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin

The aim of this study is to compare two therapeutical strategies concerning the combination therapy (peginterferon alfa-2a and ribavirin) in naïve patients with chronic hepatitis C of

interferon
fibrosis
peginterferon
combination therapy
chronic hepatitis
  • 14 views
  • 07 Nov, 2020
  • 1 location
Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders

This study aims to assess the role of ribavirin as an adjuvant to sofosbuvir/velpatasvir/voxilaprevir combination in retreatment of chronic hepatitis C with previous treatment failure.

  • 0 views
  • 13 Jan, 2021
  • 1 location
Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

genotype 1-4 co-infected with HIV-HCV, treated with Peginterferón alfa-2a (40 KD) 180 µg/week and Ribavirin (2000 mg/day during 4 weeks, follow of 1000-1200 mg/day, according to body weight

HIV Infection
blood pregnancy test
chronic hepatitis
ribavirin
ribonucleic acid
  • 10 views
  • 07 Nov, 2020
  • 38 locations
Vitamin D Treatment in Patients With Chronic Hepatitis C

Ribavirin, there will be an increase in their sustained virological response.

chronic hepatitis
interferon
chronic hepatitis c genotype 1
ribavirin
  • 10 views
  • 07 Nov, 2020
  • 1 location